Clinical Trial Update: A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002) [Phase 1]

View source ↗

Summary

This document notes a Phase 1 clinical trial (V118C-002) evaluating a novel pneumococcal vaccine (V118C) in children, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infection

Drugs mentioned

• V118C

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pneumococcal Infection | Phase 1 | Status: RECRUITING